4.5 Editorial Material

I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease Therapies

Journal

JAMA NEUROLOGY
Volume 74, Issue 9, Pages 1027-+

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2017.1528

Keywords

-

Funding

  1. Food and Drug Administration [FD004319]
  2. Pharmaceutical Research and Manufacturers of America (Regulatory Science Postdoctoral Fellowship)
  3. Griffin Foundation
  4. Michael J. Fox Foundation for Parkinson's Research
  5. Auspex Pharmaceuticals
  6. AZTherapies
  7. Banner Health
  8. Columbia University
  9. Dart Neurosciences
  10. Decibel Therapeutics
  11. Huntington Study Group
  12. JAMA Neurology
  13. Jazz Pharmaceuticals
  14. Lysosomal Therapeutics
  15. Michael J. Fox Foundation
  16. Northwestern University
  17. Partners Health Care
  18. Sarepta Therapeutics
  19. Teva Pharmaceuticals
  20. University of California Irvine
  21. University of Michigan
  22. University of Rochester

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available